Alembic Pharmaceuticals : Press Release April

For Immediate Release

Q1 Net Revenue at Rs 648 Crores, Net Profit at Rs 65 CroresVadodara July 2ot2017

Alembic Pharmaceuticals Limited reported its consolidated financial results forthe first

h

quarter ending 301

June 2017.

Financial Highlights

• Net Sales for the quarter atRs 648crores against Rs 737crores lastyear.

• Net Profit for the quarter at Rs 65crores against Rs 102crores last year.

  Mr.Pranav Amin, Managing Director, Alembic Pharmaceuticals Limited said "The performance in the quarter was weak primarily due to thetransit ional provision of GST on the India Branded business.Our expansion is progressing well and our Oncology facility was recently inaugurated by the Honorable Chief Minister of Gujarat, Shri Vijaybhai Rupani"

  Operational Highlightsfor the quarter International Business

• International formulation business revenuewas Rs 282 crores against Rs 309 crores lastyear

• US formulation business revenue was Rs 211 crores for the quarter

• 6 ANDA approvals received during the quarter,CumulativeANDA approvals at

  58

• 6 ANDA filings during the quarter, Cumulative ANDA filings at 101

• R&D spend at Rs 94 Crores, approximately 14% of Sales.

  India FormulationsBusiness

• India formulations business for the quarterat Rs 236crores as against Rs 299 crores last year

ALEMBIC PHARMACEUTICALSLIMITED

REG.OFFICE :ALEBICROAD, VADODARA• 390 003.•TEL :[phone] •FAX :[phone]

website:www.alemb1cpharmaceuticals.com • E mail:[e-mail].n• CIN :L24230GJ2010PLC061123

Summary of Total Revenue is as under:

(Rs in Crores)

Particulars	Q1 FY18	Q1 FY17
Formulation	282	309
International
India	236	299
API	130	129
Total	648	737

The Profit break-up is as under:

(Rs in Crores)

Particulars	Q1 FY18	Q1 FY17
EBITDA PreR&D	195	237
EB/TOA Pre R&D%	30%	32%
EBITDAPost R&D	105	157
EB/TOA Post R&D%	16%	21%
Profit Before Tax	79	137
Net Profit after Tax	65	102

ALEMBIC PHARMACEUTICALS LIMITED

REGO. OFFICE :ALEMBIC ROAD,VAOODARA • 390 003. • TEL :[phone] • FAX :[phone]

website :www.alamblcpharmaceutlcals.com •E•mail :[e-mail]. n • CIN :L24230GJ2010PLC061123

AboutAlembic PharmaceuticalsLimited

Alembic Pharmaceuticals Limited, avertically integrated research anddevelopment pharmaceuticalcompany, hasbeen atthe forefront of healthcare since 1907.Headquartered in lndia1Alembic isa publiclylisted company that manufactures andmarkets genericpharmaceutical products allover the world. Alembic's stateof the artresearch and manufacturing facilitiesare approved by regulatory authorities of manydeveloped countries including theUS FDA. Alembic isone ofthe leaders in brandedgenerics in India.Alembic's brands,marketed through a marketing teamof over 5000are well recognized by doctors and patients.

Information about the company can be found at www.alembicpharmaceuticals.com; (reuters:ALEM.NS) (bloomberg:ALPM) (nse:APLLTD) (bse:533573)

For more informationcontact:

Aja yKumar DesaiMitanshu Shah

Phone: [phone] Phone: [phone]

Email:ajay.desai@al_ernlli c.o.i nEmail:mitanshu.shah@al emi c:_c:c,._i _n

ALEMBIC PHARMACEUTICALS LIMITED

REGO. OFFICE :ALEMBIC ROAD, ADODARA •390 003.•TEL :[phone] • FAX ;[phone]

website :www.alemblcpharmaceut1cals.com • E mail :[e-mail] •CIN:L24230GJ2010PLC061123